Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.
Cognito Therapeutics is a venture-backed company in the development of therapeutic approaches for brain health, focusing on Alzheimer's disease and neurodegenerative conditions. They are seeking a motivated Embedded Firmware Engineer to contribute to their innovative software development team, designing, developing, and maintaining high-quality embedded firmware solutions. This is a contract position with the potential to release data in summer 2026.
Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.
A2e Technologies